| 000 | 01916cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030311.0 | ||
| 008 | 101025s2010 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.07.M.Sc.2010.Ra.A | ||
| 100 | 0 | _aRania Srag Eldin Sayed | |
| 245 | 1 | 0 |
_aAssociation of factor V leiden and prothrombin gene mutations with thrombotic risk in patients with sickle cell anemia / _cRania Srag Eldin Sayed ; Supervised Mona Salah Eldin Hamdy , Heba Mahmoud Gouda , Iman Abdelmohsen Abdu Shaheen |
| 246 | 1 | 5 | _aالعلاقة بين التحور الجينى لعامل التجلط الخامس و البروثروبين و احتمال التجلط فى مرضى الانيميا المنجلية |
| 260 |
_aCairo : _bRania Srag Eldin Sayed , _c2010 |
||
| 300 |
_a112P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology | ||
| 520 | _aSickle cell disease ( SCD ) is a group of genetic disorders of hemoglobin that causes multisystem morbidity and an increased risk of early death . Vascular complications are an important aspect of sick cell anemia although there is controversial evidence surrounding the role of thrombosis in the complication . Among the crucial inherited risk factors are factor V Leiden ( G1619A ) and prothrombin gene G20210A mutations | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aFactor V Leiden | |
| 653 | 4 | _aProthrombin gene mutation | |
| 653 | 4 | _aSickle cell disease | |
| 700 | 0 |
_aHeba Mahmoud Gouda , _eSupervisor |
|
| 700 | 0 |
_aIman Abdelmohsen Abdu Shaheen , _eSupervisor |
|
| 700 | 0 |
_aMona Salah Eldin Hamdy , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aFatma _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c31854 _d31854 |
||